TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -2 | -12 | 5 | 24 | 22 | 14 | 8 |
| S | %wins | 100 | 50 | 50 | 0 | 50 | 50 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/22/25 16:31 | 9/18/25 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Oki Mark K | WA | O | CFO | S.d | -146 | 2.92 | 0 | -50 | -28 | 128 | D | ||||||||||||||
8/29/12 17:25 | 8/27/12 | ALXA | Alexza Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Oki Mark K | CA | O | SVP,CFO, | S | -41 | 4.14 | 2 | -10 | -73 | 4 | D | -84 | -63 | -26 | 26 | 32 | 53 | 17 | 13 | -1 | 2 | -4 | 15 | -3 | -3 |
6/8/12 16:51 | 6/6/12 | ALXA | Alexza Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Oki Mark K | CA | O | VP Fin C | S | -11 | 0.3381 | 0 | -32 | -19 | 138 | D | -89 | -79 | -67 | -48 | -44 | -17 | -11 | 0 | -3 | -26 | 13 | 32 | 46 | 30 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |